Biogen’s ALS drug gets European Commission’s marketing nod
The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.
Drugs
Health
Pharma
Drugs
Health
Pharma
US reports a third human case of highly pathogenic avian influenza
A dairy farm worker in Michigan, US, has been infected with highly pathogenic avian influenza from sick cows —the third such case in America.
Drugs
Health
Pharma
J & J to buy rights for experimental skin disorder drug for $1.25 billion
Johnson & Johnson has agreed to buy the rights for an investigational skin disorder treatment from Numab Therapeutics for $1.25 billion.
Drugs
Health
Pharma
US drug regulator clears Amgen’s biosimilar to treat rare blood disorder
The US drug regulator has approved Amen’s biosimilar, Bkemv, to treat rare blood disorders, according to a statement from the Food and Drug.
Drugs
Health
Pharma
Air pollution triggering heart diseases across the globe: WHF report
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and.
Drugs
Health
Pharma
FDA panel rejects Novo Nordisk’s weekly jab to treat type 1 diabetes
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA refused approval for a once-weekly jab to control blood sugar levels in people.
Drugs
Health
Pharma
Pfizer Inc. unveils a new $1.5 billion plan to cut costs as vaccine sales fall
Pfizer Inc., announced a $1.5 billion “multi-year” savings plan to cut costs of goods sold, on top of a similar $4 billion initiative.
Drugs
Health
Medical
CDC issues travel advisory for meningitis for Haj pilgrims to KSA
HQ Team May 23, 2024: The US Centers for Disease Control and Prevention (CDC) has warned that Muslim pilgrims traveling for the annual.
Drugs
Health
Pharma
7-fold increase in use of GLP-1 weight loss drugs among teens, young adults
Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults
Drugs
Health
Pharma
WHO deletes five pathogen-antibiotic combinations in new list, adds four
The World Health Organization, after seven years, has updated its pathogens list which has 15 families of antibiotic-resistant bacteria grouped into critical, high.